Genetically diverse cancer cells key to brain tumor resistance

January 28, 2014 by Lindsay Taylor Key
Genetically diverse cancer cells key to brain tumor resistance
In this image of mouse brain tissue containing human brain tumor cells, red dye shows invasive, stem-like cells that carry two copies of chromosome 7, while green dye depicts non-stem-like cells that carry three copies of the problematic chromosome. The cells can change into one another by adding or deleting copies of of chromosome 7. Mathematical modeling suggested the involvement of chromosome instability helps tumor cells fend off treatment. Credit: Yi-Hong Zhou

(Medical Xpress)—For a cancer cell, it pays to have a group of eccentric friends.

Like X-Men characters, a group of cancer cells with diverse physical traits is safer, because it takes different strategies to kill each member.

The more diverse the group, the better the chances are for to survive and join forces as a cohesive tumor.

A multi-university research team, including researchers with the Fralin Life Science Institute at Virginia Tech, discovered that the unique physical differences among brain tumor cells were because of chromosomal abnormalities.

Understanding the biology behind diverse cell production in cancerous brain tumors may contribute to knowledge for better treatments, according to Jianhua Xing, an associate professor of biological sciences in the College of Science and a Fralin Life Science Institute affiliate.

Xing, with Yi-Hong Zhou, an assistant professor of neurological surgery in the School of Medicine at the University of California-Irvine, concluded that tumor cells with genes that have varying numbers of copies of chromosome 7 leads to cell diversity and survival of brain tumors.

Cancer cells bypass the surveillance systems that limit the number of copies of chromosomes in to produce an abnormal number of chromosomes.

Zhou, whose research program is devoted to developing novel drugs to treat brain cancer, led the experimental portion of the project, and Xing, an expert in mathematical modeling of biological systems, analyzed the results.

The discovery was published in November in PLOS One.

"Cancer is a biological entity that continues to evolve, where the cancer ecosystem, with its dynamic interactions among cancer cells and normal cells, selects the best cells to survive," Zhou said. "Our findings presented only one aspect, among many others, that use to change, with mis-segregation of chromosomes clearly being the most powerful one. By applying this concept of cancer survivability, a rewarding therapeutic approach might be developed through reducing random or chance development of , which we are currently investigating."

The project involved 21 members from the University of California-Irvine, Virginia Tech, the Veterans Affairs Medical Center at Long Beach, the University of Arkansas for Medical Sciences academic health center, Ziren Research LLC, and the National Engineering Center for Biochip at Shanghai in China.

Key work was done by Yuanjie Hu, a graduate student at the University of California-Irvine; Hang Zhang of Hebei, China, a graduate student at Virginia Tech; Xiao-Jun Tian, a postdoctoral associate at Virginia Tech; and two research specialists—Ning Ru of the University of California-Irvine and Neil T. Hoa of the Veterans Affairs Medical Center at Long Beach.

"While it's unlikely that this finding is the only mechanism that controls cancer plasticity, it is a piece of the puzzle," said Xing. "Cancer are, unfortunately, very smart. That is why the battle against cancer is so difficult."

Explore further: New study shows promise for preventing therapy resistance in tumor cells

More information: Hu Y, Ru N, Xiao H, Chaturbedi A, Hoa NT, et al. (2013) "Tumor-Specific Chromosome Mis-Segregation Controls Cancer Plasticity by Maintaining Tumor Heterogeneity." PLoS ONE 8(11): e80898. DOI: 10.1371/journal.pone.0080898

Related Stories

New study shows promise for preventing therapy resistance in tumor cells

January 9, 2014
A new study led by University of Kentucky researchers suggests that activating the tumor suppressor p53 in normal cells causes them to secrete Par-4, another potent tumor suppressor protein that induces cell death in cancer ...

Number of cancer stem cells might not predict outcome in HPV-related oral cancers

January 22, 2014
(Medical Xpress)—New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that it may be the quality ...

To stay a step ahead of breast cancer, make a map of the future

January 23, 2014
Cancer isn't a singular disease, even when talking about one tumor. A tumor consists of a varied mix of cells whose complicated arrangement changes all the time, especially and most vexingly as doctors and patients do their ...

New breast cancer stem cell findings explain how cancer spreads

January 14, 2014
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes ...

How prostate cancer cells evolve

December 4, 2013
(Medical Xpress)—UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. 

Killer cocktail fights brain cancer

November 25, 2013
A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.

Recommended for you

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients

October 23, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...

New study shows how cells can be led down non-cancer path

October 23, 2017
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells. In a ...

Microbiologists contribute to possible new anti-TB treatment path

October 23, 2017
As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved ...

Big Data shows how cancer interacts with its surroundings

October 23, 2017
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they ...

Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

October 23, 2017
Hospitalized patients with advanced cancer who report more intense and numerous physical and psychological symptoms appear to be at risk for longer hospital stays and unplanned hospital readmissions. The report from a Massachusetts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.